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Nicola Maffulli1,2Professor Nicola Maffulli is a Consultant Orthopaedic
and Sports Injury Surgeon and has published over 800
peer reviewed articles in scientific journals and 12 books
on Orthopaedic Surgery and in Sports Medicine. Profes-
sor Maffulli has a particular scientific interest in the
physiopathology of sports injuries, including anterior
cruciate ligament and tendon injuries, and great exper-
tise in arthroscopic techniques of the knee and foot and
ankle. He was Professor of Trauma and Orthopaedic
Surgery at Keele University School of Medicine (2001–
2008), Centre Lead and Professor of Sports and Exercise
Medicine at Queen Mary University of London, Barts,
and The London School of Medicine and Dentistry,
London (2008–2013), and has now taken up the Chair
in Musculoskeletal Disorders in Salerno University
School of Medicine, Italy, while maintaining an Honor-
ary Chair at Queen Mary University of London.
A keen athlete in his younger days, his boyhood dream
of going to the Olympic Games eventually came true
as in London 2013 he was the Field of Play doctor for
the Olympic Wrestling Tournament, and led a group of
seven orthopaedic surgeons to administer the Ortho-
paedic Foot and Ankle care for both the Olympics and
the Paralympics. He is one of small handful of surgeons
to have been awarded the FRCP (Fellowship of the Royal
College of Physicians).
He is the Immediate Past President of the Sport and
Exercise Section of the Royal Society of Medicine, and
the President of the European Federation of the National
Societies of Orthopaedic Sports Trauma (EFOST) forCorrespondence: n.maffulli@qmul.ac.uk
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more than 40 new surgical techniques in the field of
knee, foot and ankle and sports surgery, and many have
now become standard practice in these fields.
In this interview, we explore the field of musculoskel-
etal regenerative medicine and find out what Professor
Maffulli would like to see submitted to his section.What does the musculoskeletal regenerative
medicine field involve?
Regenerative medicine has been defined as a new field of
applied medicine aimed at replacing or regenerating hu-
man cells, tissues, or organs to restore or establish normal
function. In the musculoskeletal system, regenerative medi-
cine involves muscles, ligaments, tendons, articular cartil-
age, menisci and bone. There is an additional complication
with regenerative medicine in that all these new tissues
have to be innervated and appropriately vascularised. This
is a real challenge for the scientists in the field, as the pro-
cedures can often be quite complex in connecting up these
new tissues properly.What is the most common mechanism of injury
in sport?
No one single mechanism is responsible. Broadly speak-
ing, we see acute injuries due to trauma, overuse injuries
from excessive prolonged training, and chronic injuries
when an injury has been underestimated and the athlete
tries to return to sport too early. Often, these mecha-
nisms of injury are avoidable and link back to athletes
being aware of their body’s limitations and what they
can and should be achieving with training.his is an Open Access article distributed under the terms of the Creative
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musculoskeletal regenerative medicine over the
last few years and where are we today?
The field is still in its infancy and while there have been
some promising reports, these haven’t yet translated into
clinical trials and treatments. The future is bright, though,
and inevitably things are happening. At present, there are
some preliminary studies which show that for example,
stem cells can be successfully added to the standard man-
agement of osteo-articular injuries, but routine use is still
far away. Researchers are becoming more imaginative, and
marrying several fields: tissue engineering, molecular biol-
ogy, and genetics. What appears to be a necessity is to
have greater inter-disciplinary communication, and to be
able to span medicine, biology and engineering.
Which tissues have been shown to particularly
benefit from stem cell therapy?
Bone and cartilage have attracted the most interest. Some
clinical studies are available, and await to be repeated by
independent centres. Muscles, ligaments and tendons are
probably the ultimate frontier in this field, especially given
how common injuries to these structures are, and how
troublesome and unpredictable their management is.
Are there any particular injuries that are
especially difficult to manage?
Yes. Chronic overuse injuries of the soft tissues are the
most challenging. This is probably because we have not
yet learnt how best to cope with them appropriately and
this is something which requires ongoing work and re-
search. In this respect, these modern techniques of stem
cell research and tissue engineering may constitute a real
revolution.
What are the main problems or challenges with
stem cell therapy and how can research
contribute to meeting these challenges?
Stem cell therapy has had a lot of hype recently, but little
research output and medical applications have emerged as
of yet. While some studies have been conducted, those
that have been especially well-performed have unfortu-
nately been singularly negative. We are still struggling, but
many groups are undertaking groundbreaking work and
so the future looks positive. Eventually, we shall find the
right cell and the right stimuli, and then stem cell therapy
will be able to be widely used in sports medicine for the
treatment of serious injuries and for the improvement
of athlete strength and performance. Most of this work is
expensive, and therefore its application is still limited to
laboratory studies. Nevertheless, the programme, for ex-
ample, in Pittsburgh, USA led by Professor Fu and his
group, is state of the art, with great opportunities for
translation into everyday clinical practice.As a clinician in the field, what do you think is
the most important aspect to consider when
treating athletes, both now and in the future?
A major issue is to make athletes understand that
healing after injury takes time. From my viewpoint, the
most common cause of failure of a well-performed treat-
ment is attempts at early return to sport. To tackle this,
regular contact with a sports practitioner is essential
alongside stressing the importance of appropriate rest
and recovery, ensuring that the body is stronger for
training and competing.
Where are we with helping athletes to effectively
regain their full potential after injury?
We are now able to perform many surgical procedures
in a less invasive fashion, and we are perfecting our re-
habilitation techniques, resulting in reduced injury time.
If we were able to harvest the potential of regenerative
medicine, we would be able to make a real breakthrough!
What will the new BMC Sports Science, Medicine
and Rehabilitation bring to the sports medicine
community?
This is a new and exciting opportunity to spread the
word. The open access publishing model will allow
everybody to read original research in the field, and will
allow researchers to publish under one single banner.
The importance of the visibility that open access guaran-
tees in this key area of research cannot be overstated, as
any new discovery can be immediately disseminated
throughout the sports medicine community and follow-
up studies can be put together.
What kind of manuscripts would you like to see
submitted to your section?
I am particularly interested in manuscripts on the topic
of tissue engineering, gene expression, and novel tech-
niques to optimise musculoskeletal cell cultures. The
field of molecular and cellular modelling is still in its in-
fancy, but manuscripts in these areas would be equally
welcome in the section as they are important and grow-
ing areas of research. We welcome original research,
commentaries and reviews on all these topics for consid-
eration for peer review.
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